Kavli Affiliate: John Rubenstein
| Authors: Siavash Fazel Darbandi, Joon-Yong An, Kenneth Lim, Nicholas F. Page, Lindsay Liang, Athena R. Ypsilanti, Eirene Markenscoff-Papadimitriou, Matthew W. State, Alex S. Nord, Stephan J. Sanders and John L. R. Rubenstein
| Summary:
Abstract The authors have withdrawn their manuscript because of uncertainty about an antibody reagent that was used in the paper. Therefore, the authors are withdrawing the manuscript until further notice to address this issue and do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author Competing Interest Statement J.L.R.R. is cofounder and stockholder, and currently on the scientific board, of Neurona, a company studying the potential therapeutic use of interneuron transplantation. S.J.S. receives research funding from BioMarin Pharmaceutical. M.W.S. is a consultant to BlackThorn and ArRett Pharmaceuticals. L.L. is a stockholder and employee of Invitae. All other authors declare no competing interests.